BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19697155)

  • 1. Predictive value of serial measurements of quality of life on all-cause mortality in prostate cancer patients: data from CaPSURE (cancer of the prostate strategic urologic research endeavor) database.
    Sadetsky N; Hubbard A; Carroll PR; Satariano W
    Qual Life Res; 2009 Oct; 18(8):1019-27. PubMed ID: 19697155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
    Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
    BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer Registry.
    Ten Ham RMT; Broering JM; Cooperberg MR; Carroll P; Wilson LS
    Clin Genitourin Cancer; 2020 Feb; 18(1):e21-e27. PubMed ID: 31796344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE.
    Downs TM; Sadetsky N; Pasta DJ; Grossfeld GD; Kane CJ; Mehta SS; Carroll PR; Lubeck DP
    J Urol; 2003 Nov; 170(5):1822-7. PubMed ID: 14532784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between health-related quality-of-life scores and clinical outcomes in metastatic castration-resistant prostate cancer patients: Exploratory analyses of AFFIRM and PREVAIL studies.
    Beer TM; Miller K; Tombal B; Cella D; Phung D; Holmstrom S; Ivanescu C; Skaltsa K; Naidoo S
    Eur J Cancer; 2017 Dec; 87():21-29. PubMed ID: 29096157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting quality of life after radical prostatectomy: results from CaPSURE.
    Hu JC; Elkin EP; Pasta DJ; Lubeck DP; Kattan MW; Carroll PR; Litwin MS
    J Urol; 2004 Feb; 171(2 Pt 1):703-7; discussion 707-8. PubMed ID: 14713791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: data from CaPSURE.
    Arredondo SA; Elkin EP; Marr PL; Latini DM; DuChane J; Litwin MS; Carroll PR;
    Urology; 2006 Mar; 67(3):559-65. PubMed ID: 16527580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term quality of life following primary treatment in men with clinical stage T3 prostate cancer.
    Namiki S; Tochigi T; Ishidoya S; Ito A; Numata I; Arai Y
    Qual Life Res; 2011 Feb; 20(1):111-8. PubMed ID: 20680687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor.
    Lubeck DP; Litwin MS; Henning JM; Stier DM; Mazonson P; Fisk R; Carroll PR
    Urology; 1996 Nov; 48(5):773-7. PubMed ID: 8911524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE.
    Arredondo SA; Downs TM; Lubeck DP; Pasta DJ; Silva SJ; Wallace KL; Carroll PR
    J Urol; 2004 Nov; 172(5 Pt 1):1830-4. PubMed ID: 15540732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between utility and treatment among patients with prostate cancer.
    Jayadevappa R; Schwartz JS; Chhatre S; Wein AJ; Malkowicz SB
    Qual Life Res; 2010 Jun; 19(5):711-20. PubMed ID: 20204704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of health-related quality of life in men with prostate cancer: the CaPSURE database.
    Lubeck DP; Litwin MS; Henning JM; Carroll PR
    Qual Life Res; 1997 Jul; 6(5):385-92. PubMed ID: 9290305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
    Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of postprostatectomy external beam radiotherapy on quality of life: results from the Cancer of the Prostate Strategic Urologic Research Endeavor.
    Hu JC; Elkin EP; Krupski TL; Gore J; Litwin MS
    Cancer; 2006 Jul; 107(2):281-8. PubMed ID: 16779794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.
    Cooperberg MR; Broering JM; Carroll PR
    J Natl Cancer Inst; 2009 Jun; 101(12):878-87. PubMed ID: 19509351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial.
    Fizazi K; Scher HI; Miller K; Basch E; Sternberg CN; Cella D; Forer D; Hirmand M; de Bono JS
    Lancet Oncol; 2014 Sep; 15(10):1147-56. PubMed ID: 25104109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials.
    Ediebah DE; Quinten C; Coens C; Ringash J; Dancey J; Zikos E; Gotay C; Brundage M; Tu D; Flechtner HH; Greimel E; Reeve BB; Taphoorn M; Reijneveld J; Dirven L; Bottomley A;
    Cancer; 2018 Aug; 124(16):3409-3416. PubMed ID: 29905936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life and risk of colorectal cancer recurrence and All-cause death among advanced stages of colorectal cancer 1-year after diagnosis.
    Wong CK; Law WL; Wan YF; Poon JT; Lam CL
    BMC Cancer; 2014 May; 14():337. PubMed ID: 24886385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.
    Quinten C; Coens C; Mauer M; Comte S; Sprangers MA; Cleeland C; Osoba D; Bjordal K; Bottomley A;
    Lancet Oncol; 2009 Sep; 10(9):865-71. PubMed ID: 19695956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer.
    Penson DF; Litwin MS; Lubeck DP; Flanders S; Pasta DJ; Carroll PR
    Prostate Cancer Prostatic Dis; 1998 Mar; 1(3):134-143. PubMed ID: 12496906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.